White blood cell count remains low after five days of white blood cell-boosting injections.

After five days of white blood cell-boosting injections, if white blood cells remain low, it is usually due to inadequate control of the underlying disease and severe suppression of bone marrow function.

White blood cell-boosting injections are a recombinant human granulocyte colony-stimulating factor (G-CSF). Their main function is to stimulate bone marrow hematopoiesis, promoting the production of white blood cells to compensate for deficiencies in the body. These injections are primarily used to treat low neutrophil and white blood cell counts caused by chemotherapy for cancer, as well as conditions such as aplastic anemia, myelodysplastic syndromes, and leukemia.

In cases where treatment with white blood cell-boosting injections proves ineffective or shows little improvement, this situation commonly occurs among chemotherapy patients. Chemotherapeutic agents such as paclitaxel, etoposide, and capecitabine can cause significant bone marrow suppression. If medication fails and white blood cell counts continue to drop, chemotherapy should be discontinued. For non-chemotherapy patients—for example, those with myelodysplastic syndromes or aplastic anemia—management should be determined based on the treatment plan and medications used for their primary condition when white blood cell levels fall below normal.

If there is no improvement despite prolonged use of white blood cell-boosting injections, patients should promptly report this to their doctor. After identifying the underlying cause, the treatment plan should be adjusted accordingly without delay.